Krintafel 150 MG Oral Tablet
- RxCUI
- 2109239
- RxNorm name
- Krintafel 150 MG Oral Tablet
- Display name
- Krintafel 150 MG Oral Tablet
- Full name
- Krintafel 150 MG Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:00
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Krintafel | TAFENOQUINE SUCCINATE | GlaxoSmithKline LLC | 5cf989d5-36f5-4561-a30b-9fcb9deb6b6a | 2023-08-02 | Warnings, Adverse reactions | 2109239 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 5cf989d5-36f5-4561-a30b-9fcb9deb6b6a | Krintafel 150 MG Oral Tablet [PSN] · tafenoquine 150 MG Oral Tablet [Krintafel] [SBD] · Krintafel 150 MG Oral Tablet [SY] | 3 | 12 | These highlights do not include all the information needed to use KRINTAFEL safely and effectively. See full prescribing information for KRINTAFEL. KRINTAFEL (tafenoquine) tablets, for oral use Initial U.S. Approval: 2018 | 20230802 |